ATAI Life Sciences is set to become the new industry leader among psychedelic stocks. But it may not be the best OPPORTUNITY for investors when trading begins.
Psychedelics
Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds
Mindset has filed multiple patent applications regarding "both novel prodrug and deuterated derivatives of psilocybin".
Tryp Therapeutics Announces Strategic Investment of $2,000,000
Tryp Therapeutics announces a CAD$2.0 private placement at a unit price of CAD$0.60
New Jersey Governor Signs Psilocybin Bill To Immediately Reduce Penalties For Possession
New Jersey Gov. Phil Murphy (D) signed a psilocybin reform bill into law on Thursday, immediately reclassifying possession of up to an ounce of psychedelic-containing mushrooms as a disorderly persons offense.
Cybin Announces Closing of Upsized Bought Deal Offering
Cybin has closed on a CAD$34 million bought deal financing. Has raised nearly CAD$90 million to date.
Should psychedelic drugs be decriminalized in Mass.? Advocates see opening
Somerville in January became the first jurisdiction in Massachusetts to move toward decriminalizing plant-based psychedelic drugs, with city leaders voting unanimously to recognize the medical uses of natural entheogens — including psilocybin, the active ingredient in “magic mushrooms” — and make them among the lowest enforcement priorities for local police.
Cambridge City Council Decriminalizes Psychedelics And Urges Police To End Drug Arrests More Broadly
Cambridge, Massachusetts has become the latest city to decriminalize a wide range of psychedelics following a City Council vote on Wednesday.
The Road To Psychedelics Legalization, Part 2: Psilocybin and MDMA
Psilocybin and MDMA stand out as the two psychedelic drugs with the shortest paths to legalization.
Florida Lawmaker Wants to Legalize Psychedelic Mushrooms by 2022
Although Florida has a history of being slow on the draw when it comes to legalizing drug use (see: the failed effort to legalize recreational marijuana), a Florida lawmaker is hoping the state will take the leap into psychedelics and legalize medical mushrooms as early as 2022.
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
JR Rahn is becoming sole CEO for MindMed Inc. in what the company describes as its "MindMed 2.0 leadership team".
Microdosing Psychedelics: What Does It Mean & Is It Safe? From A Psychiatrist
Microdosing psychedelics has become a buzzworthy topic of conversation among everyone from tech CEOs to stay-at-home parents.
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
TORONTO, Feb. 2, 2021 /PRNewswire/ -- MindMed (NEO: MMED,OTCQB: MMEDF, DE: MMQ), a leading psychedelic medicine biotech company, streamlined its leadership team to further develop the company's strategy of integrating its psychedelic clinical development programs with innovative digital technologies.
More Psychedelic Companies Are Going Public
THE NASCENT PSYCHEDELIC industry is booming as several companies have gone public and more are expected to follow this route in 2021 to attract more capital from institutional and retail investors.
The Road To Psychedelics Legalization, Part 1: Psychedelics vs. Cannabis
Psychedelic Stock Watch examines the Road to Legalization for psychedelic drugs. Part 1: cannabis vs psychedelics.
Magic Mushrooms Are Reportedly Helping Some People Cope Amid Coronavirus Pandemic
A Sunday report from Global News spotlights a unique way that some people are coping with the stress and anxiety of the coronavirus pandemic — magic mushrooms.